Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
---|
12/01/2005 | WO2005067643A8 Determination of hepatitis c virus genotype |
12/01/2005 | WO2005051330B1 METHOD FOR TREATING HUMAN TUMOR CELLS WITH A NEWCASTLE DISEASE VIRUS STRAIN HAVING A p53 INDEPENDENT ONCOLYTIC EFFECT |
12/01/2005 | WO2005005614A3 Combined b-cell and t-cell epitopes on vlp for improved vaccines |
12/01/2005 | WO2003049703A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
12/01/2005 | US20050266567 Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
12/01/2005 | US20050266566 Viral vector in which gene for Sendai viral protein selected from NP, P, and L proteins is deleted or inactivated while all other gene functions are retained; use as expression vector in e.g. gene therapy; efficient system for reconstituting Sendai virus |
12/01/2005 | US20050266564 Tetracycline-regulated gene expression in HSV-1 vectors |
12/01/2005 | US20050266550 TC-83-derived alphavirus vectors, particles and methods |
12/01/2005 | US20050266544 Methods and compositions for increasing viral vector production in packaging cell lines |
12/01/2005 | US20050266439 Thermostable RNA ligase from thermus phage |
12/01/2005 | US20050266400 Novel sequences encoding hepatitis C virus glycoproteins |
12/01/2005 | US20050266026 Multi plasmid system for the production of influenza virus |
12/01/2005 | US20050266023 Generation of virus-like particles and use as panfilovirus vaccine |
12/01/2005 | US20050266020 Modular transport systems for molecular substances and production and use thereof |
12/01/2005 | US20050266019 Infectious bursal disease virus antigenic isolates and vaccines |
12/01/2005 | US20050265973 Chimeric adenoviruses for use in cancer treatment |
12/01/2005 | US20050265972 A genetic construct containing a glucose inducible regulatory element with a pair of CACGTG nucleotide sequences and confer human proinsulin expression in host hepatocyte cells; therapy for diabetes |
12/01/2005 | US20050265971 Agent for treatment of breast cancer and pancreatic cancer comprising herpes simplex virus mutant |
12/01/2005 | CA2568248A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
12/01/2005 | CA2566858A1 Process for the production of an influenza vaccine |
11/30/2005 | EP1599592A1 Infectious flavivirus pseudo-particles containing functional prm and/or e proteins |
11/30/2005 | EP1599581A2 Production of a live vaccine directed against influenza viruses |
11/30/2005 | EP1599580A1 Animal-free cell culture method |
11/30/2005 | EP1599495A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
11/30/2005 | EP1268766B1 Improvements to ribosome display |
11/30/2005 | CN1702171A Recombinant herpes simplex virus capable of excreting angiostatin and endostatin protein and its application in treating lung cancer |
11/30/2005 | CN1229501C Mixture of recombinant vaccinia vectors as poly-envelope protein vaccines for HIV |
11/29/2005 | US6969598 Methods for producing high titre vectors and compositions used in such methods |
11/29/2005 | CA2331599C Replication defective hiv vaccine |
11/24/2005 | WO2005111201A1 Vaccine comprising an attenuated pestivirus |
11/24/2005 | WO2005111200A1 Novel strains of reoviruses and methods of uses thereof |
11/24/2005 | WO2005111199A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
11/24/2005 | WO2005049077A3 Avian vaccine effective against infectious bursal disease virus |
11/24/2005 | US20050261472 Binding moieties for fibrin |
11/24/2005 | US20050261183 PTHrP-derived modulators of smooth muscle proliferation |
11/24/2005 | US20050260734 Packaging cells |
11/24/2005 | US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof |
11/24/2005 | US20050260564 Non-cytotoxic oriP replicon |
11/24/2005 | US20050260171 Compositions containing bacteriophages and method of using bacteriophages to treat infections |
11/24/2005 | US20050260169 Treatment of cancer using HSV mutant |
11/24/2005 | US20050260168 Compositions comprising viruses and methods for concentrating virus preparations |
11/24/2005 | US20050260162 Conditionally replicative adenovirus to target the Rb and Rb-related pathways |
11/24/2005 | US20050260156 Modified vaccinia virus ankara for the vaccination of neonates |
11/24/2005 | DE102004020762A1 Preparation of an oncolytic virus suspension, useful for treating cancers, comprises inoculating tumor cell lines with viruses and selecting oncolytic viruses in the culture supernatant that can form syncitia |
11/24/2005 | CA2567301A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
11/24/2005 | CA2561719A1 Vaccine comprising an attenuated pestivirus |
11/23/2005 | EP1598425A1 Modified Vaccinia Ankara virus variant |
11/23/2005 | EP1598420A2 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
11/23/2005 | EP1597376A2 Chicken rna polymerisate i promoter and the use thereof |
11/23/2005 | EP1597359A1 Inactivated nodavirus vaccine |
11/23/2005 | EP1226264B1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
11/23/2005 | EP1185628B1 Isolation of a human retrovirus |
11/23/2005 | CN1699560A Extended-spectrum beta-lactamases Escherichia coli bacteriophage and its separation and preparation method |
11/23/2005 | CN1699559A An imine-resistant bacillus pyocyaneus bacteriophage and its use for treating infection therefrom |
11/23/2005 | CN1698430A Improved storage and maintenance of blood products |
11/23/2005 | CN1228447C Recombinant expression vector expressing human pancreatic tissue kallikrein gene |
11/23/2005 | CN1228085C Forest cerebritis purifying vaccine |
11/22/2005 | CA2267639C Synthetic hpv16 virus-like particles |
11/22/2005 | CA2068066C Herpesvirus particles and vaccine |
11/17/2005 | WO2005108581A1 Recombinant virus vector for gene introduction in lymphocyte |
11/17/2005 | WO2005108560A2 Synthesis and purification of west nile virus virus-like particles |
11/17/2005 | WO2005107796A2 Cellular permissivity factor for viruses, and uses thereof |
11/17/2005 | WO2005058356A3 Methods for porducing storage stable viruses and immunogenic compositions thereof |
11/17/2005 | WO2004073736A8 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
11/17/2005 | US20050255597 Transformation of cells with vector carrying transgenic virus |
11/17/2005 | US20050255480 A norovirus-permissive cell culture, including dendritic- and macrophage-lineage cells and macrophages having a deficiency in a cellular anti-viral pathway such as a STAT-1-dependent pathway, an interferon receptor-dependent pathway, or a PKR-dependent pathway infected with a norovirus |
11/17/2005 | US20050255461 Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E |
11/17/2005 | US20050255123 Chimeric ebola virus envelopes and uses therefor |
11/17/2005 | US20050255089 adeno-associated virus 5 (AAV5) specific polynucleotides, that codes for an AAV5 specific proteins; delivering polynucleotides to cells using the AAV5 vectors and particles |
11/17/2005 | US20050255085 Prevention of recurrence and metastasis of cancer |
11/17/2005 | CA2565509A1 Recombinant virus vector for gene introduction in lymphocyte |
11/17/2005 | CA2564769A1 Cellular permissivity factor for viruses, and uses thereof |
11/16/2005 | EP1594435A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
11/16/2005 | EP1498129B1 Use of adenoviruses mutated in the va genes for cancer treatment |
11/16/2005 | EP1216053B1 Influenza vaccine |
11/16/2005 | EP1062235B1 A method for isolating and purifying soluble proteins and peptides from plant sources |
11/16/2005 | EP0741793B1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof |
11/16/2005 | CN1697884A Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
11/16/2005 | CN1697879A Biomolecule transfer method using virus envelope and composition and system therefor |
11/15/2005 | US6964762 Composition and method for stimulating immune response to pathogen using complex adenoviral vector |
11/15/2005 | CA2437962C Method of extracting virus from cell culture |
11/15/2005 | CA2155533C Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
11/10/2005 | WO2005106046A1 Modified viral vector particles |
11/10/2005 | WO2005105834A1 Method for the production of empty viral capsids in yeasts, said capsids comprising proteins derived from pvp2 of the virus that causes infectious bursal disease (ibdv) |
11/10/2005 | US20050251872 Lentiviral vectors, related reagents, and methods of use thereof |
11/10/2005 | US20050250206 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
11/10/2005 | US20050250114 Method for decreasing the number of free virus particles within the bodily fluids of a virally-infected mammal |
11/10/2005 | US20050250105 Multiple viral replicon culture systems |
11/10/2005 | US20050250093 Hepatitis c virus sub-genomic replicons |
11/10/2005 | US20050249707 Stimulating an immune response in human or animal, by administering a gene, infected DENDRITIC CELLS; without preventing antigen processing occurring within the infected cell; increase gene expression on the surface of tumour cells; protection against cancer; vaccines |
11/10/2005 | US20050249705 Inactivated herpes simplex virus glycoprotein for treating metastasis; ultraviolet radiation and heating; highly safe |
11/10/2005 | US20050247630 Methods for removal, purification, and concentration of viruses and methods of therapy based thereupon |
11/09/2005 | EP1593738A1 Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier |
11/09/2005 | EP1261693B1 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors |
11/09/2005 | EP0812359B1 Group o hiv-1, fragments of such viruses, and uses thereof |
11/09/2005 | CN1694958A Gene expression system based on codon translation efficiency |
11/09/2005 | CN1694898A HBV precore protein capable of forming particles |
11/09/2005 | CN1693455A Mosaic type swine circular ring virus PCV 1.2 and its construction method use |
11/08/2005 | US6963021 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
11/08/2005 | US6962777 VLP-containing compositions produced express conformational, neutralizing epitopes and have high homogeneity and therefore comprise effective diagnostic and prophylactic agents for diagnosis or prevention of papillomavirus infections |